In summary, our findings indicate that imbalance of Tfh and Tfr is important for SLE severity, and low-dose IL-2 ameliorates lupus autoimmunity favoring Tfr cell expansion. The gene discussed is TFRC; the disease is systemic lupus erythematosus.